1) BOT received a CRL - it indicated the only negatives related to NON-clinical matters - meaning, IF they have all been adequately addressed, the drug should be approved - the FDA flagged NO drug related issues in the CRL.
2) All royalties are now owned by BOT - except a master 5% royalty to the lab that first developed the drug candidate - BOT bought out all the previous commercial promoters royalties - ie, all royalties now 95% owned by BOT! A VERY Wise move!!!!
I hope BOT approval drops in the next few weeks....it should be a bit early...but that's just wild speculation on my part....but given it's all packaging/labelling/diagram issues.....fingers crossed!
1) BOT received a CRL - it indicated the only negatives related...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $472.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.3¢ | $824.2K | 2.803M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 406362 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 290048 | 6 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.5¢ |
Change
0.010 ( 5.28 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 30.5¢ | 28.0¢ | 960021 | ||
| Last updated 15.58pm 24/05/2024 ? | |||||
| BOT (ASX) Chart |